BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Acceleron Pharma And Celgene Announce Updated Results From Ongoing Phase 2 Studies Of Luspatercept In Myelodysplastic Syndromes At The 58th Annual Meeting Of American Society of Hematology

  December 5, 2016

   · 

  6 min read
• Business

  Evogen And UCB Announce Collaboration For Further Development Of EvoScore START For Improved Diagnosis Of Epilepsy

  December 5, 2016

   · 

  5 min read
• Pharm Country

  Elsevier, Inc. Launches First Assessment Of Cancer Research On Global Scale In Partnership With US National Cancer Moonshot Initiative

  December 5, 2016

   · 

  4 min read
• Drug Development

  GlycoMimetics, Inc.’ GMI-1271 Continues To Yield High Remission Rates, Favorable Tolerability In Two Phase II Arms Of Ongoing Phase I/II Clinical Trial For AML

  December 5, 2016

   · 

  5 min read
• BioForest

  Omeros’ Proprietary Orphan GPCR Program Delivers New Target And Approach In Cancer Immunotherapy

  December 5, 2016

   · 

  8 min read
• Drug Development

  Syros Pharma Presents Data At American Society of Hematology Annual Meeting Further Supporting Clinical Potential Of Its First-In-Class Selective Rara Agonist For Genomically Defined Subsets Of AML And MDS Patients

  December 5, 2016

   · 

  8 min read
• Business

  Purdue Pharma L.P. And Anabios Collaborate To Advance Research For Non-Opioid, Non-NSAID Treatments For Chronic Pain

  December 5, 2016

   · 

  5 min read
• New 10-Minute Test From Mettler-Toledo Can Improve Moisture Analysis

  December 5, 2016

   · 

  2 min read
• Biotech Bay

  True North Therapeutics Presents Additional Data From An Ongoing Clinical Study Showing Normalization Of Hemoglobin Levels With TNT009 In Severely Anemic Cold Agglutinin Disease (CAD) Patients

  December 5, 2016

   · 

  4 min read
• Drug Development

  Acetylon Presents Early Phase 1a/1b Results For Citarinostat (ACY-241) In Combination With Pomalyst And Dexamethasone Showing Promising Treatment Responses In Relapsed Or Relapsed-And-Refractory Multiple Myeloma

  December 5, 2016

   · 

  5 min read